MAPI Research Trust provides reliable, comprehensive and up-to-date information services to research scientists, pharmaceutical companies, and governmental health agencies involved in the fields of Patient-Reported Outcomes (PRO) and Pharmaco-Epidemiology worldwide.
Home SERVICES Questionnaire Licensing
GHQ (General Health Questionnaire) PDF Print E-mail

Developed by:
David P Goldberg (UK)

Objective:
Screening instrument to detect psychiatric disorders in community settings and non-psychiatric clinical settings, such as primary care or general practice.

Copyright:
GHQ-12 copyright © David Goldberg, 1978./ GHQ-28 copyright © David Goldberg and the Institute of Psychiatry, 1981./ GHQ-30 copyright © David Goldberg, 1978./ GHQ-60 copyright © David Goldberg and the Institute of Psychiatry, 1978.

Published by GL Assessment Limited, The Chiswick Centre, 414 Chiswick High Road, London W4 5TF, UK. All rights reserved. GL Assessment is a part of the Granada Learning Group.

Reference publications:

Goldberg DP. The detection of psychiatric illness by questionnaire. London, Oxford University Press, 1972
Goldberg DP et al. Manual of the General Health Questionnaire. Windsor, England, NFER Publishing, 1978
Goldberg DP, Hillier VF. A scaled version of the General Health Questionnaire. Psychol Med. 1979 Feb;9(1):139-45
Vieweg BW, and Hedlund JL . The General Health Questionnaire (GHQ): A comprehensive review. Journal of Operational Psychiatry 1983; 14(2), 74-81
Goldberg DP, Oldehinkel T, Ormel J. Why GHQ threshold varies from one place to another. Psychol Med 1998 ;28(4):915-21


Conditions of use:

1. Registration and Licensing with GL Assessment:

The use of the GHQ is licensed by GL Assessment.
A license agreement must be completed and User fee is required.

Please contact:

GL Assessment
FREEPOST LON16517
Swindon
SN2 8BR

Email: This e-mail address is being protected from spambots. You need JavaScript enabled to view it
Website: www.gl-assessment.co.uk

2. Distribution of translations:

MAPI Research Trust has been contracted by GL Assessment, the copyright owner and publisher of the GHQ, for the international distribution of the GHQ translations.
To receive a copy of the needed translation(s) from MAPI Research Trust, you must first register with GL Assessment.

Then, please provide MAPI Research Trust with a copy of the signed GL Assessment license agreement for the use of the GHQ in your project.

    A. Access to existing translations (see also #3 Translation Agreement):

carre6 For existing validated translations: User is required to complete and sign a User Agreement in which specific conditions required by the copyright owner are detailed.

Please contact MAPI Research Trust at This e-mail address is being protected from spambots. You need JavaScript enabled to view it for the list of existing GHQ translations (validated or not validated).

carre6 Processing fees for existing validated translation(s): Access to the GHQ is subject to the following distribution fees (MAPI Research Trust) and per translation royalty fees (GL Assessment):

- In not-funded academic research (1) and individual clinical practice: free of charge
- In funded academic research (2): 300 €* per study + 50 €* per language version + 50 €* royalty fee
- In commercial studies (3) involving "for-profit" organizations: 500 €* per study + 150 €* per language 
   version + 150 €* royalty fee

* excluding VAT

(1) Not funded academic research: if the project is not explicitly funded, but funding comes from overall departmental funds or from the University or individual funds then fees are waived.

(2) Funded academic research: projects receiving funding from commerce, government, EU should anticipate paying the corresponding fees.

(3) Commercial studies (industry, CRO, any for-profit companies).


    B. New Translations or additionnal linguistic validation work on existing translations:

The GHQ has already been translated into various languages. However, most of the existing translations have not been validated or have not undergone a full linguistic validation process and additional work may be necessary. If not available in the language(s) required, a Linguistic Validation must be undergone.

Please contact This e-mail address is being protected from spambots. You need JavaScript enabled to view it for list of existing translations (validated or not validated).

Conditions to translate:

To be granted permission to translate the GHQ, please complete the GHQ Translation Agreement.

The Translation Agreement shall complement the User Agreement. All GHQ translations must be conducted in close collaboration with MAPI Institute in Lyon, France and with GL Assessment who jointly developed translation guidelines to fit the GHQ specificities. GL Assessment owns the copyright on any new translation (refer to the User and Translation Agreements for more detailed about conditions of use).

  1. Commercial and/or International studies
    In order to undertake the linguistic validation of the GHQ questionnaire, funds are needed to support the whole translation process. Please contact the MAPI Institute at This e-mail address is being protected from spambots. You need JavaScript enabled to view it for an estimate of time and cost to translate/validate the needed version(s).

  2. Academic translations / Not funded research and Evaluation studies
    If funds are not available, GHQ translation guidelines will be provided to allow academics and clinicians to use the GHQ in their institution.


Review copy:

Original UK English of the GHQ-12, GHQ-28, GHQ30 and GHQ-60 versions available for review purpose only. Please click here to access.

Contact information:

MAPI Research Trust
Christelle Berne

27 rue de la Villette
F - 69003 LYON
Tel: +33 4 72 13 65 75
Fax: +33 4 72 13 66 82

This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Please have the User Agreement and when applicable the Translation Agreement completed, dated and signed and return one original copy to MAPI Research Trust by post. As soon as we receive them, we will process your request.

More information on GHQ on PROQOLID


[ BACK ]

 

New questionnaires distributed by MAPI Research Trust

ADCPQ (Alzheimer’s Disease Caregiver Preference Questionnaire)  
Novartis Pharmaceuticals Corporation (USA)

FIS (Fatigue Impact Scale)
D-FIS (Daily Fatigue Impact Scale)
John Fisk (Canada)  

HIV-SQUAD (Symptom Quality of Life Adherence) Questionnaire ®
Abbott France (France) 

MOS-HIV (Medical Outcome Study-HIV Health Survey)
Albert Wu (USA)

MPQ (McGill Pain Questionnaire)
Ronald Melzack (Canada)

MPQ-SF (McGill Pain Questionnaire - Short Form)
Ronald Melzack (Canada)

Nausea Questionnaire 
Ronald Melzack (Canada)

ODI (Oswestry Disability Questionnaire)
Jeremy Fairbank (UK)

PHQ (Patient Health Questionnaire Screeners
Pfizer Inc. (USA)

PRAC-Test (PRAgmatic Content and face validity Test)
Mapi Values (France)

SF-MPQ-2 (Short-form McGill Pain Questionnaire)
Ronald Melzack (Canada) and IMMPACT (USA) 


To access our catalog, please click here.



Coming soon!

Crohn and Anti-tnf Treatment Satisfaction questionnaire
Abbott France (France)


For any information, please contact:
contact@mapi-trust.org